<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin J Pain</journal-id><journal-id journal-id-type="iso-abbrev">Clin J Pain</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>The Clinical journal of pain</journal-title></journal-title-group><issn pub-type="ppub">0749-8047</issn><issn pub-type="epub">1536-5409</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10127144</article-id><article-id pub-id-type="pmcid-ver">PMC10127144.1</article-id><article-id pub-id-type="pmcaid">10127144</article-id><article-id pub-id-type="pmcaiid">10127144</article-id><article-id pub-id-type="manuscript-id">NIHMS1879360</article-id><article-id pub-id-type="pmid">37094085</article-id><article-id pub-id-type="doi">10.1097/AJP.0000000000001105</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1879360</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1879360</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>DULOXETINE, GABAPENTIN, AND THE RISK FOR ACUTE MYOCARDIAL INFARCTION, STROKE, AND OUT-OF-HOSPITAL DEATH IN MEDICARE BENEFICIARIES WITH NON-CANCER PAIN</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Corriere</surname><given-names initials="MA">Meghan A.</given-names></name><degrees>PhD</degrees><aff id="A1">Department of Medicine, Vanderbilt University Medical Center</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dickson</surname><given-names initials="AL">Alyson L.</given-names></name><degrees>MS</degrees><aff id="A2">Department of Medicine, Vanderbilt University Medical Center</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Daniel</surname><given-names initials="LL">Laura L.</given-names></name><degrees>PhD</degrees><aff id="A3">Department of Medicine, Vanderbilt University Medical Center</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nepal</surname><given-names initials="P">Puran</given-names></name><degrees>MS</degrees><aff id="A4">Department of Medicine, Vanderbilt University Medical Center</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hall</surname><given-names initials="K">Kathi</given-names></name><degrees>BA</degrees><aff id="A5">Department of Medicine, Vanderbilt University Medical Center</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Plummer</surname><given-names initials="WD">W. Dale</given-names></name><degrees>BS</degrees><aff id="A6">Department of Biostatistics, Vanderbilt University Medical Center</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dupont</surname><given-names initials="WD">William D.</given-names></name><degrees>PhD</degrees><aff id="A7">Department of Biostatistics, Vanderbilt University Medical Center</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Murray</surname><given-names initials="KT">Katherine T.</given-names></name><degrees>MD</degrees><aff id="A8">Department of Medicine, Vanderbilt University Medical Center</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stein</surname><given-names initials="CM">C. Michael</given-names></name><degrees>MBChB</degrees><aff id="A9">Department of Medicine, Vanderbilt University Medical Center</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ray</surname><given-names initials="WA">Wayne A.</given-names></name><degrees>PhD</degrees><aff id="A10">Department of Health Policy, Vanderbilt University Medical Center</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chung</surname><given-names initials="CP">Cecilia P.</given-names></name><degrees>MD MPH</degrees><aff id="A11">Department of Medicine, Vanderbilt University Medical Center</aff></contrib></contrib-group><author-notes><corresp id="CR1">Corresponding author: Cecilia P. Chung, MD, MPH, Associate Professor of Medicine, Division of Rheumatology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, <email>c.chung@vumc.org</email>. Phone: 615-322-4746. Fax: 615-322-6248.</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>5</month><year>2023</year></pub-date><pub-date pub-type="collection"><day>01</day><month>5</month><year>2023</year></pub-date><volume>39</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">434218</issue-id><fpage>203</fpage><lpage>208</lpage><pub-history><event event-type="nihms-submitted"><date><day>17</day><month>03</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 11:25:31.053"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1879360.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objective:</title><p id="P1">Duloxetine is a serotonin-norepinephrine reuptake inhibitor prescribed for musculoskeletal and other forms of chronic pain. Its dual pharmacologic properties have the potential to either raise or lower cardiovascular risk: adrenergic activity may increase the risk for acute myocardial infarction (AMI) and stroke, but antiplatelet activity may decrease risk. With current emphasis on the use of non-opioid medications to treat patients with chronic pain, assessing cardiovascular risks associated with these medications among high-risk patients is important.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We conducted a retrospective cohort study among a 20% sample of Medicare enrollees, aged 65 to 89, with chronic pain who were new users between 2015 and 2018 of either duloxetine (n=34,009) or gabapentin (n=233,060). We excluded individuals with cancer or other life-threatening conditions at study drug initiation. The primary outcome was a composite of AMI, stroke, and out-of-hospital mortality. We adjusted for comorbidity differences with time-dependent inverse probability of treatment weighting.</p></sec><sec id="S3"><title>Results:</title><p id="P3">During 115,668 person-years of follow-up, 2,361 patients had the composite primary outcome; the rate among new users of duloxetine was 16.7/1,000 person-years compared to new users of gabapentin (21.1/1,000 person-years), adjusted HR=0.98 (95% CI: 0.83, 1.16). Results were similar for the individual components of the composite outcome as well as in analyses stratified by demographic and clinical characteristics.</p></sec><sec id="S4"><title>Discussion:</title><p id="P4">In summary, cohort Medicare patients with non-cancer pain beginning treatment with duloxetine had rates of AMI, stroke, and out-of-hospital mortality comparable to those who initiated gabapentin.</p></sec></abstract><kwd-group><kwd>chronic pain</kwd><kwd>duloxetine</kwd><kwd>cardiovascular risk</kwd><kwd>pharmacoepidemiology</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>